NCT06614140 2024-09-26Personalized Neoantigen Cancer Vaccine for Patients with Solid TumorsSeqker Biosciences, Inc.Phase 1/2 Active not recruiting8 enrolled
NCT01079741 2018-02-13Safety Study of Adjuvant Vaccine to Treat Melanoma PatientsIcahn School of Medicine at Mount SinaiPhase 1/2 Completed34 enrolled 10 charts